These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26845943)

  • 1. [Treatment choice of the antiviral agent for the hepatitis C].
    Karino Y
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():269-73. PubMed ID: 26845943
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of new hepatitis C treatments in different regions of the world.
    Wei L; Lok AS
    Gastroenterology; 2014 May; 146(5):1145-50.e1-4. PubMed ID: 24662488
    [No Abstract]   [Full Text] [Related]  

  • 3. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Invited Lecture; 5. New strategy of hepatitis C virus of treatment].
    Kumada H
    Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2084-97. PubMed ID: 27522756
    [No Abstract]   [Full Text] [Related]  

  • 4. New hepatitis C therapies.
    Pawlotsky JM
    Semin Liver Dis; 2014 Feb; 34(1):7-8. PubMed ID: 24782253
    [No Abstract]   [Full Text] [Related]  

  • 5. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.
    Herion D; Hoofnagle JH
    Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233
    [No Abstract]   [Full Text] [Related]  

  • 6. Bayesian network meta-analysis to evaluate interferon-free treatments in naive patients with genotype 1 hepatitis C virus infection.
    Trippoli S; Fadda V; Maratea D; Messori A
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):983-4. PubMed ID: 26114910
    [No Abstract]   [Full Text] [Related]  

  • 7. New Drug Treats All Genotypes of Chronic HCV.
    Aschenbrenner DS
    Am J Nurs; 2016 Oct; 116(10):27. PubMed ID: 27684768
    [No Abstract]   [Full Text] [Related]  

  • 8. Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection.
    Knops E; Heger E; Koenig C; Moebius U; Lübke N; Kaiser R; Di Cristanziano V; Hüsgen L; Kocyigit C; Rupp J; Sierra S
    Clin Microbiol Infect; 2018 Apr; 24(4):440-441. PubMed ID: 29104172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Predictive factors of response to Direct Acting Antivirals therapy Drug resistance hepatitis C virus].
    Suda G; Yamasaki K; Sakamoto N
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():189-92. PubMed ID: 26845928
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment for hepatitis C under hemodialysis].
    Izumi N
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():294-9. PubMed ID: 26845948
    [No Abstract]   [Full Text] [Related]  

  • 11. Focus.
    Samuel D
    J Hepatol; 2010 Jan; 52(1):3-4. PubMed ID: 19923033
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of Direct-Acting Antivirals Compared with Older Agents for Hepatitis C.
    Ta K; Zehtabchi S
    Am Fam Physician; 2017 Jun; 95(11):Online. PubMed ID: 28671433
    [No Abstract]   [Full Text] [Related]  

  • 13. Current therapy of hepatitis C.
    de Knegt RJ
    Scand J Gastroenterol Suppl; 2006; (243):65-9. PubMed ID: 16782624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Host cholesterol biosynthesis as a potential target for anti-hepatitis C virus strategies].
    Saito K; Fukasawa M
    Seikagaku; 2016 Jun; 88(3):411-5. PubMed ID: 27483962
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C: changing genotype distribution with important implications for patient management.
    van Soest H; Boland GJ; van Erpecum KJ
    Neth J Med; 2006 Apr; 64(4):96-9. PubMed ID: 16609154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Hepatitis C awareness, searching for it and referral for therapy"].
    Zeuzem S
    MMW Fortschr Med; 2006 Apr; 148(16):8. PubMed ID: 16688939
    [No Abstract]   [Full Text] [Related]  

  • 17. Tailoring antiviral therapy in hepatitis C.
    Davis GL
    Hepatology; 2006 May; 43(5):909-11. PubMed ID: 16628667
    [No Abstract]   [Full Text] [Related]  

  • 18. New hepatitis C therapies: the toolbox, strategies, and challenges.
    Pawlotsky JM
    Gastroenterology; 2014 May; 146(5):1176-92. PubMed ID: 24631495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical consequences of hepatitis C virus quasispecies for target-specific antivirals.
    Fanning LJ
    J Infect Dis; 2008 Sep; 198(6):797-9. PubMed ID: 18637751
    [No Abstract]   [Full Text] [Related]  

  • 20. In brief: Hepatic injury with hepatitis C drugs.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):156. PubMed ID: 26529136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.